desogestrel has been researched along with Hypercoagulability in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 11 (73.33) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergendal, A; Björgell, O; Holmström, M; Kieler, H; Odeberg, J; Persson, I; Schulman, S; Sundström, A | 1 |
| Al Dieri, R; Bloemen, S; Hemker, HC; Ten Cate, H; Ten Cate-Hoek, A | 1 |
| Berg, E; Bremme, K; Hamad, RR; Stenflo, J; Strandberg, K | 1 |
| Algra, A; Bouma, BN; Grobbee, DE; Kemmeren, JM; Meijers, JC | 2 |
| Fabris, F; Girolami, A; Girolami, B; Spiezia, L; Vianello, F | 1 |
| Hillarp, A; Lindqvist, PG; Malmquist, A; Rosing, J | 1 |
| Bertina, RM; Dahm, AE; Helmerhorst, FM; Rosendaal, FR; Rosing, J; Sandset, PM; van Vliet, HA | 1 |
| Deam, S; Dolan, G; Gould, J | 1 |
| Kluft, C | 1 |
| Bouma, BN; Büller, HR; Meijers, JC; Middeldorp, S; Prins, MH; Rosing, J; Tans, G; van den Ende, AE; van Enk, A | 1 |
| Bouma, BN; Büller, HR; Meijers, JC; Middeldorp, S; Prins, MH; Rosing, J; Tans, G; Tekelenburg, W; van den Ende, AE | 1 |
| Bouma, BN; Büller, HR; Curvers, J; Meijers, JC; Middeldorp, S; Prins, MH; Rosing, J; Tans, G; Thomassen, MC | 1 |
| Gabriel, HH; Hilberg, T; Müller-Berghaus, G; Nowacki, PE | 1 |
| Brocco, G; Franchini, M; Guidi, G; Lippi, G; Manzato, F | 1 |
7 trial(s) available for desogestrel and Hypercoagulability
| Article | Year |
|---|---|
The APC-PCI concentration as an early marker of activation of blood coagulation: a study of women on combined oral contraceptives.
Topics: Adult; Antithrombin III; Blood Coagulation; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Humans; Levonorgestrel; Peptide Hydrolases; Protein C; Protein C Inhibitor; Thrombophilia; Young Adult | 2012 |
Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation.
Topics: Activated Protein C Resistance; Adult; Carboxypeptidase B2; Contraceptives, Oral, Hormonal; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Factor V; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Levonorgestrel; Thrombophilia | 2002 |
Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
Topics: Adolescent; Adult; Antithrombin III; Biomarkers; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Humans; Levonorgestrel; Peptide Fragments; Peptide Hydrolases; Prothrombin; Risk Factors; Thrombin; Thrombophilia; Venous Thrombosis | 2000 |
Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Topics: Adolescent; Adult; alpha-2-Antiplasmin; Biomarkers; Blood Proteins; Carboxypeptidase B2; Carboxypeptidases; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Factor XI; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysin; Fibrinolysis; Humans; Levonorgestrel; Netherlands; Peptide Fragments; Plasminogen; Plasminogen Activator Inhibitor 1; Prothrombin; Thrombophilia; Tissue Plasminogen Activator | 2000 |
A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
Topics: Activated Protein C Resistance; Adolescent; Adult; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombins; Biomarkers; Blood Coagulation; Blood Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Netherlands; Partial Thromboplastin Time; Protein C; Protein C Inhibitor; Protein S; Thrombin; Thrombophilia | 2000 |
Changes in blood coagulation and fibrinolysis associated with maximal exercise and physical conditioning in women taking low dose oral contraceptives.
Topics: Adult; Analysis of Variance; Blood Coagulation; Conditioning, Psychological; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Exercise Test; Female; Fibrinolysis; Humans; Levonorgestrel; Physical Education and Training; Physical Exertion; Probability; Reference Values; Thrombophilia | 2000 |
Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Topics: Activated Protein C Resistance; Adult; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Factor IX; Factor V; Factor VII; Female; Humans; Levonorgestrel; Peptide Fragments; Prothrombin; Thrombophilia | 2002 |
8 other study(ies) available for desogestrel and Hypercoagulability
| Article | Year |
|---|---|
Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes.
Topics: Adult; Body Mass Index; Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Factor V; Female; Humans; Middle Aged; Point Mutation; Progestins; Risk Assessment; Risk Factors; Smoking; Sweden; Thrombophilia; Venous Thromboembolism | 2014 |
Procoagulant effect of vitamin K antagonists?
Topics: Activated Protein C Resistance; Androstenes; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Female; Humans; Lipoproteins; Protein S; Thrombophilia | 2011 |
Changes in prescription patterns of oral contraceptives in a northern Italian province: relation with venous thromboembolism.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Prescriptions; Drug Utilization; Female; Humans; Incidence; Italy; Middle Aged; Norpregnenes; Progesterone Congeners; Risk Factors; Thromboembolism; Thrombophilia; Venous Thrombosis | 2003 |
Etonogestrel implant use is not related to hypercoagulable changes in anticoagulant system.
Topics: Adult; Blood Coagulation Tests; Contraceptive Agents, Female; Desogestrel; Female; Humans; Progesterone Congeners; Thrombophilia | 2003 |
Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor.
Topics: Activated Protein C Resistance; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Lipoproteins; Middle Aged; Protein S; Thrombophilia | 2008 |
Prothrombin 20210A polymorphism and third generation oral contraceptives--a case report of coeliac axis thrombosis and splenic infarction.
Topics: Adolescent; Alleles; Celiac Plexus; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Disease Susceptibility; Dysmenorrhea; Female; Genetic Testing; Genotype; Humans; Point Mutation; Polymorphism, Genetic; Prothrombin; Splenic Infarction; Thrombophilia; Thrombosis | 1998 |
Renewed interest in haemostasis changes induced by oral contraceptives (OCs)
Topics: Activated Protein C Resistance; Adult; Biomarkers; Blood Coagulation Factors; Blood Proteins; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Genetic Predisposition to Disease; Hemostasis; Humans; Levonorgestrel; Partial Thromboplastin Time; Randomized Controlled Trials as Topic; Thrombophilia; Venous Thrombosis | 2000 |
Prothrombotic effects and clinical implications of third-generation oral contraceptives use.
Topics: Adult; Antithrombin III; Blood Coagulation Tests; Contraceptives, Oral, Synthetic; Desogestrel; Drug Evaluation; Ethinyl Estradiol; Female; Hemostasis; Humans; Norpregnenes; Protein C; Protein S; Reference Values; Thrombophilia | 2002 |